血流动力学病变严重度与分布预测未来急性冠脉综合征风险
EMERALD-II 研究纳入 351 例 ACS 患者,回顾其事件前 1 个月至 3 年的冠状动脉 CTA,分析 873 支血管。研究评估 FFRCT 与 PPGCT 定义的病变严重度和分布,并结合管腔及斑块特征。结果显示血流动力学局灶性病变 ACS 风险最高,且独立于管腔狭窄和易损斑块特征。
要点
- 冠状动脉 CTA 报告时关注 FFRCT≤0.80 且 PPGCT>0.60 的局灶性病变,其 ACS 风险最高。
- FFRCT 降低和 PPGCT 升高均与 ACS 风险独立相关,PPGCT 可补充 FFRCT 的预后信息。
- 血流动力学局灶性病变在非阻塞性病变和非 HRP 中仍有独立预测价值,需留意不依赖狭窄程度的病灶。
核心结论
- 血流动力学病变分布指标 PPGCT 可补充 FFRCT 预测 ACS 风险,局灶性病变是独立预测因子和潜在预防靶点。
研究设计与样本
- 国际多中心内部病例对照研究 EMERALD-II,纳入 351 例 ACS 患者。
- 患者在事件发生前 1 个月至 3 年接受冠状动脉 CTA 检查,共分析 873 支血管。
- 通过侵入性冠状动脉造影与冠状动脉 CTA 匹配确定罪犯血管与非罪犯血管。
- 由核心实验室评估 HRP 特征,包括最小管腔面积 <4 mm²、斑块负荷 ≥70%、低衰减斑块、正性重构、点状钙化和餐巾环征。
- 从冠状动脉 CTA 衍生 FFRCT 和 PPGCT,将血管分为非缺血、弥漫性、混合和局灶性四类。
关键影像表现/征象
- HRP 特征包括最小管腔面积 <4 mm²、斑块负荷 ≥70%、低衰减斑块、正性重构、点状钙化和餐巾环征。
- PPGCT 通过回撤压力梯度评估病变空间分布,用于区分弥漫性与局灶性血流动力学模式。
- 血流动力学局灶性病变定义为 FFRCT≤0.80 且 PPGCT>0.60,表现为病变节段内血流动力学异常相对局限。
诊断标准与关键数值
- 平均 FFRCT 为 0.74±0.17,平均 PPGCT 为 0.54±0.14。
- FFRCT 每升高 0.1,ACS 风险 OR 为 0.71(95% CI 0.65-0.77,P<0.001)。
- PPGCT 每升高 0.1,ACS 风险 OR 为 1.22(95% CI 1.09-1.37,P<0.001)。
- 血流动力学局灶性病变 ACS 相对风险 RR 为 2.02(95% CI 1.74-2.36,P<0.001)。
- 血流动力学局灶性病变心肌梗死 RR 为 1.75(95% CI 1.43-2.14,P<0.001),不稳定型心绞痛 RR 为 2.54(95% CI 2.00-3.22,P<0.001)。
临床应用与阅片要点
- 日常报告冠状动脉 CTA 时,可结合 FFRCT 和 PPGCT 识别局灶性血流动力学病变,其 ACS 风险最高。
- 即使管腔狭窄不严重或无 HRP 特征,局灶性血流动力学异常仍提示较高 ACS 风险,报告时应避免仅凭管腔狭窄程度判断。
- 与单独使用 FFRCT 和 PPGCT 的模型相比,最大病变水平 ΔFFRCT 显示更好的模型性能,PPGCT 在 ΔFFRCT≥0.10 时提供额外风险评估价值。
局限性
- 研究为内部病例对照设计,病例均来自 ACS 患者,缺少完全无事件人群的对照分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Although physiological assessment has been used in decision-making for revascularization, its role in predicting the future risk of acute coronary syndrome (ACS) remains underexplored.
OBJECTIVES: This study aims to investigate the independent and combined prognostic significance of hemodynamic disease severity and distribution in identifying ACS culprit vessels, in conjunction with lumen and plaque characteristics.
METHODS: The EMERALD-II study is an international, multicenter, internal case-control study enrolling 351 patients with ACS who underwent coronary computed tomography angiography (CTA) 1 month to 3 years before the event. Culprit and nonculprit vessels were identified by matching invasive coronary angiography with coronary CTA findings. High-risk plaque (HRP) characteristics, including minimum lumen area <4 mm2, plaque burden ≥70%, low-attenuation plaque, positive remodeling, spotty calcification, and napkin-ring sign, were assessed by a core laboratory, with HRP defined as ≥3 HRP characteristics. From coronary CTA, the authors derived both the hemodynamic severity of the disease (fractional flow reserve derived from computed tomography [FFRCT]) and its spatial distribution (diffuse vs focal), as assessed by the pullback pressure gradient derived from coronary CTA (PPGCT). Vessels were categorized into 4 hemodynamic disease patterns: nonischemic (FFRCT >0.80), hemodynamic diffuse (FFRCT ≤0.80 and PPGCT ≤0.50), mixed (FFRCT ≤0.80 and 0.50 < PPGCT ≤0.60), and focal disease (FFRCT ≤0.80 and PPGCT >0.60).
RESULTS: Among 873 vessels, the mean FFRCT was 0.74 ± 0.17 and the mean PPGCT was 0.54 ± 0.14. Both lower FFRCT and higher PPGCT were independently associated with higher ACS risk (OR per 0.1 increase in FFRCT: 0.71 [95% CI: 0.65-0.77]; P < 0.001; OR per 0.1 increase in PPG: 1.22 [95% CI: 1.09-1.37]; P < 0.001). Among the 4 subgroups of hemodynamic disease pattern, hemodynamic focal disease showed the highest risk of ACS (relative risk [RR]: 2.02 [95% CI: 1.74-2.36]; P < 0.001), myocardial infarction (RR: 1.75 [95% CI: 1.43-2.14]; P < 0.001), and unstable angina (RR: 2.54 [95% CI: 2.00-3.22]; P < 0.001). It remained a predictor for ACS in nonobstructive lesions (OR: 3.56 [95% CI: 1.43-8.84]), obstructive lesions (OR: 3.16 [95% CI: 1.96-5.07]), non-HRP (OR: 6.69 [95% CI: 3.59-12.5]), and HRP (OR: 2.98 [95% CI: 1.83-4.87]). Although the maximal lesion-level ΔFFRCT (differences in FFRCT across the lesion) demonstrated superior model performance compared with models incorporating FFRCT and PPGCT, higher PPGCT was additionally associated with increased ACS risk, particularly among vessels with maximal ΔFFRCT ≥0.10.
CONCLUSIONS: Hemodynamic disease distribution, as measured by PPGCT, complements FFRCT in predicting ACS risk. The integration of hemodynamic disease patterns provides additional prognostic value beyond lumen and plaque characteristics, with hemodynamic focal disease emerging as an independent predictor and a potential therapeutic target for ACS prevention. (Exploring the Mechanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and Computational Fluid Dynamics II [EMERALD II]; NCT03591328).
引用
- Yang, Chung, Park, et al. Association of Hemodynamic Disease Severity and Distribution With Risk of Future Acute Coronary Syndrome. JACC Cardiovasc Imaging. 2026. PMID: 42412030. doi:10.1016/j.jcmg.2026.05.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。